These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15837940)

  • 1. Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women.
    Tankó LB; Bagger YZ; Qin G; Alexandersen P; Larsen PJ; Christiansen C
    Circulation; 2005 Apr; 111(15):1883-90. PubMed ID: 15837940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians.
    Rosenbaum P; Gimeno SG; Sanudo A; Franco LJ; Ferreira SR;
    Diabetes Obes Metab; 2005 Jul; 7(4):352-9. PubMed ID: 15955121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferred clinical measures of central obesity for predicting mortality.
    Welborn TA; Dhaliwal SS
    Eur J Clin Nutr; 2007 Dec; 61(12):1373-9. PubMed ID: 17299478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women.
    Royer M; Castelo-Branco C; Blümel JE; Chedraui PA; Danckers L; Bencosme A; Navarro D; Vallejo S; Espinoza MT; Gómez G; Izaguirre H; Ayala F; Martino M; Ojeda E; Onatra W; Saavedra J; Tserotas K; Pozzo E; Manriquez V; Prada M; Grandia E; Zuniga C; Lange D; Sayegh F;
    Climacteric; 2007 Apr; 10(2):164-70. PubMed ID: 17453865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
    Misra KB; Endemann SW; Ayer M
    Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.
    Hunt KJ; Resendez RG; Williams K; Haffner SM; Stern MP;
    Circulation; 2004 Sep; 110(10):1251-7. PubMed ID: 15326061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome, abdominal obesity, and cardiovascular risk in elderly women.
    Cabrera MA; Gebara OC; Diament J; Nussbacher A; Rosano G; Wajngarten M
    Int J Cardiol; 2007 Jan; 114(2):224-9. PubMed ID: 16784787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm.
    Wassink AM; van der Graaf Y; Olijhoek JK; Visseren FL;
    Eur Heart J; 2008 Jan; 29(2):213-23. PubMed ID: 18199567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
    Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C
    Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions.
    Guize L; Thomas F; Pannier B; Bean K; Jego B; Benetos A
    Diabetes Care; 2007 Sep; 30(9):2381-7. PubMed ID: 17563336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease.
    Postorino M; Marino C; Tripepi G; Zoccali C;
    J Am Coll Cardiol; 2009 Apr; 53(15):1265-72. PubMed ID: 19358939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile.
    Blackburn P; Lemieux I; Alméras N; Bergeron J; Côté M; Tremblay A; Lamarche B; Després JP
    Metabolism; 2009 Aug; 58(8):1123-30. PubMed ID: 19481769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-cause and cardiovascular mortality using the different definitions of metabolic syndrome.
    Benetos A; Thomas F; Pannier B; Bean K; Jégo B; Guize L
    Am J Cardiol; 2008 Jul; 102(2):188-91. PubMed ID: 18602519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome.
    Ko GT; So WY; Chan NN; Chan WB; Tong PC; Li J; Yeung V; Chow CC; Ozaki R; Ma RC; Cockram CS; Chan JC
    Diabetes Obes Metab; 2006 Jan; 8(1):94-104. PubMed ID: 16367887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes, the metabolic syndrome, and angiographic progression of coronary arterial disease in postmenopausal women.
    Mellen PB; Cefalu WT; Herrington DM
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):189-93. PubMed ID: 16239594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.
    DECODE Study Group
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):192-9. PubMed ID: 17446796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.